Home Dialysis Expansion Quanta Dialysis Technologies has recently launched an FDA 510(k) submission for the home use of the Quanta Dialysis System. This presents a significant sales opportunity to cater to patients seeking dialysis treatment in the comfort of their homes.
Strategic Executive Appointment With the appointment of Alejandro Galindo as the Chief Executive Officer, Quanta Dialysis Technologies is poised for strategic growth and innovation. Leveraging his expertise, there are potential avenues to explore new markets and expand product reach, creating opportunities for sales expansion.
Award-Winning Innovations Quanta Dialysis Technologies has been recognized for its engineering innovations, winning prestigious awards such as the MacRobert Award and the 2022 innovation award for the SC+ Hemodialysis system. These accolades enhance the company's credibility in the market, opening doors for increased sales and partnerships.
Top Engineering Innovation Being acknowledged as the UK's top engineering innovation of 2022 underscores Quanta Dialysis Technologies' commitment to revolutionizing dialysis care. This recognition can be leveraged by the sales team to showcase the company's expertise and quality products, potentially attracting new clients and expanding market share.
Board of Directors Appointment By appointing industry experts like Leslie Norwalk to the Board of Directors, Quanta Dialysis Technologies strengthens its leadership and strategic direction. This move enables the company to build valuable connections, drive business growth, and explore new sales opportunities through enhanced industry networks and insights.
1-888-653-2347 
support@leadiq.com 
